Net platelet clot strength of thromboelastography platelet mapping assay for the identification of high on-treatment platelet reactivity in post-PCI patients

High-on treatment platelet reactivity (HTPR) leads to more prevalence of thrombotic event in patients undergoing percutaneous coronary interventions (PCI). Dual antiplatelet therapy with aspirin in addition to one P2Y(12) inhibitor is commonly administrated to reduce HTPR. However, ‘one size fits al...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Daye, Zhao, Shuo, Hao, Yiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Diagnostics & Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364512/
https://www.ncbi.nlm.nih.gov/pubmed/32639536
http://dx.doi.org/10.1042/BSR20201346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364512/
https://www.ncbi.nlm.nih.gov/pubmed/32639536
http://dx.doi.org/10.1042/BSR20201346

Ejemplares similares